Live Breaking News & Updates on Ception Therapeutics

Stay updated with breaking news from Ception therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Benralizumab reduces eosinophils but does not improve eosinophilic gastritis

Treatment with benralizumab induced histological remission, defined as an absence of tissue eosinophilia, among patients with eosinophilic gastritis, according to a study published in The Lancet Gastroenterology & Hepatology.But the persistence of signs, symptoms and biomarkers of the disease during treatment suggested a pathogenic mechanism independent of eosinophil levels in many patients, ....

United States , Kristen Dowd , Gastroenterol Hepatol , Tucker Ellis , Serpin Pharm , Byrichard Gawel , Revolo Biotherapeutics , Marce Rothenberg , Food Allergy Fund , Cincinnati Children Hospital Medical Center , Bristol Myers Squibb , International Eosinophil Society , Israel Binational Grant , Ception Therapeutics , Mapi Research Trust , Pediatric Eosinophilic Esophagitis Symptom Score , Nextstone One , Cincinnati Children , Hospital Medical Center , Pulmone Therapeutics , Spoon Guru , Lancet Gastroenterology , Lancet Gastroenterol Hepatol , Dyspepsia Assessment , Patient Reported Outcome Measurement Information ,

Growing geriatric population will boost the eosinophilic esophagitis drug market, forecast to reach


Search jobs
12-Mar-2021
Growing geriatric population will boost the eosinophilic esophagitis drug market, forecast to reach US$ 135 Mn by 2025 with a CAGR of 6%
Noida, Uttar Pradesh, India, March 12 2021 (Wiredrelease) Report Ocean Pvt Ltd –:The growing geriatric population, rising demand for early detection of diseases, and increasing prevalence of target diseases are key factors driving the market’s growth. The overall market for eosinophilic esophagitis drugs is also witnessing a surge in demand owing to increasing point-of-care testing and personalized medicine. Besides this, the market also benefited from increasing government funding to improve healthcare facilities and increase focus on innovations from the market players. Following these promising developments, the Global Eosinophilic Esophagitis Drug Market is estimated to see healthy growth, pegged at a CAGR of around 6% throughout the forecast period 2020-20 ....

Uttar Pradesh , United States , Falk Pharma Gmb , Bristol Myers Squibb , Regeneron Pharmaceuticals , Adare Pharmaceuticals Inc , Wiredrelease Report Ocean Pvt Ltd , Wiredrelease News Department , Arena Pharmaceuticals , Ocean Pvt Ltd , Allakos Inc , Report Ocean Pvt Ltd , Global Eosinophilic Esophagitis Drug Market , Sample Report , Asia Pacific , Global Eosinophilic Esophagitis Drug , Product Type , Distribution Channel , Product Type Outlook , Distribution Channel Outlook , Hospital Pharmacy , Retail Pharmacy , Application Outlook , Adare Pharmaceuticals , Falk Pharma Gmbh , Ception Therapeutics ,